These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 26845136)
1. 8-bromo-7-methoxychrysin Reversed M2 Polarization of Tumor-associated Macrophages Induced by Liver Cancer Stem-like Cells. Sun S; Cui Y; Ren K; Quan M; Song Z; Zou H; Li D; Zheng Y; Cao J Anticancer Agents Med Chem; 2017; 17(2):286-293. PubMed ID: 26845136 [TBL] [Abstract][Full Text] [Related]
2. Reversal of liver cancer-associated stellate cell-induced stem-like characteristics in SMMC-7721 cells by 8-bromo-7-methoxychrysin via inhibiting STAT3 activation. Cui Y; Sun S; Ren K; Quan M; Song Z; Zou H; Li D; Cao J Oncol Rep; 2016 May; 35(5):2952-62. PubMed ID: 26935885 [TBL] [Abstract][Full Text] [Related]
3. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells. Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863 [TBL] [Abstract][Full Text] [Related]
4. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin. Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896 [TBL] [Abstract][Full Text] [Related]
5. 8-Bromo-7-methoxychrysin-blocked STAT3/Twist axis inhibits the stemness of cancer stem cell-like cell originated from SMMC-7721 cells. Luo Y; Cui Y; Cao X; Li X; Chen A; Zhang J; Chen X; Cao J Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):458-464. PubMed ID: 28369327 [TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line. Zou H; Cao X; Xiao Q; Sheng X; Ren K; Quan M; Song Z; Li D; Zheng Y; Zeng W; Cao J; Peng Y Oncol Rep; 2016 Sep; 36(3):1731-8. PubMed ID: 27461522 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of triggering receptor expressed on myeloid cells 1 inhibits invasion and migration of liver cancer cells by mediating macrophage polarization. Chen M; Lai R; Lin X; Chen W; Wu H; Zheng Q Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649843 [TBL] [Abstract][Full Text] [Related]
8. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling. Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349 [TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648 [TBL] [Abstract][Full Text] [Related]
10. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway. Wang H; Wang X; Li X; Fan Y; Li G; Guo C; Zhu F; Zhang L; Shi Y Cancer Lett; 2014 Apr; 345(1):91-9. PubMed ID: 24333724 [TBL] [Abstract][Full Text] [Related]
11. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages. Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048 [TBL] [Abstract][Full Text] [Related]
13. Individualized precision treatment: Targeting TAM in HCC. Li Z; Wu T; Zheng B; Chen L Cancer Lett; 2019 Aug; 458():86-91. PubMed ID: 31129147 [TBL] [Abstract][Full Text] [Related]
14. [Over-expression of receptor-interacting protein 140 in tumor-associated macrophages suppresses invasion and proliferation of hepatoma cells in vitro]. Yi ZJ; Zhou Y; Zhang WF; Chen H; Zhao W; Liu ZJ; Gong JP Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1461-1467. PubMed ID: 27881334 [TBL] [Abstract][Full Text] [Related]
15. Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. Sprinzl MF; Puschnik A; Schlitter AM; Schad A; Ackermann K; Esposito I; Lang H; Galle PR; Weinmann A; Heikenwälder M; Protzer U J Hepatol; 2015 Apr; 62(4):863-70. PubMed ID: 25463538 [TBL] [Abstract][Full Text] [Related]
16. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569 [TBL] [Abstract][Full Text] [Related]
17. M2 polarized macrophages induced by CSE promote proliferation, migration, and invasion of alveolar basal epithelial cells. Fu X; Shi H; Qi Y; Zhang W; Dong P Int Immunopharmacol; 2015 Sep; 28(1):666-74. PubMed ID: 26253658 [TBL] [Abstract][Full Text] [Related]
18. β,β-Dimethylacrylalkannin, a Natural Naphthoquinone, Inhibits the Growth of Hepatocellular Carcinoma Cells by Modulating Tumor-Associated Macrophages. Shen LS; Lin Z; Gong RH; Lin YS; Qiao XF; Hu QM; Qin WH; Chen S; Yang Y; Chen GQ Molecules; 2024 Aug; 29(16):. PubMed ID: 39202998 [TBL] [Abstract][Full Text] [Related]
19. Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment. Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4205-4218. PubMed ID: 38041778 [TBL] [Abstract][Full Text] [Related]
20. Sunitinib suppresses M2 polarization of macrophages in tumor microenvironment to regulate hepatocellular carcinoma progression. Kong Y; Guo L J Biochem Mol Toxicol; 2023 Jun; 37(6):e23333. PubMed ID: 36797997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]